These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 24261083)
1. Investigation of Pokemon-regulated proteins in hepatocellular carcinoma using mass spectrometry-based multiplex quantitative proteomics. Bi X; Jin Y; Gao X; Liu F; Gao D; Jiang Y; Liu H Eur J Mass Spectrom (Chichester); 2013; 19(2):111-21. PubMed ID: 24261083 [TBL] [Abstract][Full Text] [Related]
2. Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells. Hu H; Ding X; Yang Y; Zhang H; Li H; Tong S; An X; Zhong Q; Liu X; Ma L; Liu Q; Liu B; Lu Z; Zhang D; Hu P; Ren H Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G611-22. PubMed ID: 24994855 [TBL] [Abstract][Full Text] [Related]
3. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951 [TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma. Li C; Ruan HQ; Liu YS; Xu MJ; Dai J; Sheng QH; Tan YX; Yao ZZ; Wang HY; Wu JR; Zeng R J Proteome Res; 2012 Feb; 11(2):871-85. PubMed ID: 22082227 [TBL] [Abstract][Full Text] [Related]
5. A secretomic study on human hepatocellular carcinoma multiple drug-resistant cell lines. Xiang Y; Liu Y; Yang Y; Hu H; Hu P; Ren H; Zhang D Oncol Rep; 2015 Sep; 34(3):1249-60. PubMed ID: 26151126 [TBL] [Abstract][Full Text] [Related]
6. Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription. Kong J; Liu X; Li X; Wu J; Wu N; Chen J; Fang F Hepatol Int; 2016 May; 10(3):493-500. PubMed ID: 26797719 [TBL] [Abstract][Full Text] [Related]
7. Depletion of Pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras. Zhang QL; Tian DA; Xu XJ Onkologie; 2011; 34(10):526-31. PubMed ID: 21985851 [TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers. Li C; Tan YX; Zhou H; Ding SJ; Li SJ; Ma DJ; Man XB; Hong Y; Zhang L; Li L; Xia QC; Wu JR; Wang HY; Zeng R Proteomics; 2005 Mar; 5(4):1125-39. PubMed ID: 15759316 [TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues. Gao Y; Wang X; Sang Z; Li Z; Liu F; Mao J; Yan D; Zhao Y; Wang H; Li P; Ying X; Zhang X; He K; Wang H Sci Rep; 2017 Apr; 7():45913. PubMed ID: 28378759 [TBL] [Abstract][Full Text] [Related]
10. In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery. Zhang J; Hao N; Liu W; Lu M; Sun L; Chen N; Wu M; Zhao X; Xing B; Sun W; He F Br J Cancer; 2017 Nov; 117(11):1676-1684. PubMed ID: 29024941 [TBL] [Abstract][Full Text] [Related]
11. Pokemon siRNA Delivery Mediated by RGD-Modified HBV Core Protein Suppressed the Growth of Hepatocellular Carcinoma. Kong J; Liu X; Jia J; Wu J; Wu N; Chen J; Fang F Hum Gene Ther Methods; 2015 Oct; 26(5):175-80. PubMed ID: 26356810 [TBL] [Abstract][Full Text] [Related]
12. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530 [TBL] [Abstract][Full Text] [Related]
13. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics. Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725 [TBL] [Abstract][Full Text] [Related]
14. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas. Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558 [TBL] [Abstract][Full Text] [Related]
15. miR-125/Pokemon auto-circuit contributes to the progression of hepatocellular carcinoma. Kong J; Liu X; Li X; Wu J; Wu N; Chen J; Fang F Tumour Biol; 2016 Jan; 37(1):511-9. PubMed ID: 26227218 [TBL] [Abstract][Full Text] [Related]
16. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies. Ritorto MS; Borlak J J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509 [TBL] [Abstract][Full Text] [Related]
17. Differential proteomic analysis of hepatocellular carcinoma. Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837 [TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma. Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164 [TBL] [Abstract][Full Text] [Related]
19. Pokemon reduces Bcl-2 expression through NF-κ Bp65: A possible mechanism of hepatocellular carcinoma. Zhao X; Ning Q; Sun X; Tian D Asian Pac J Trop Med; 2011 Jun; 4(6):492-7. PubMed ID: 21771706 [TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of differently expressed proteins in human hepatocellular carcinoma cell lines HepG2 with transfecting hepatitis B virus X gene. Li WH; Miao XH; Qi ZT; Ni W; Zhu SY; Fang F Chin Med J (Engl); 2009 Jan; 122(1):15-23. PubMed ID: 19187611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]